Genetic and epigenetic markers of low density lipoprotein-cholesterol receptors in management of Type 2 diabetes mellitus and newer treatment options
based on genome-wide association scan (GWAS) findings yield inconclusive results. The burden of CAD in T2DM is high, increased levels of Low-Density Lipoprotein cholesterol remains prevalent. This paper ... English…

